SCHEDULE: Divisadero Street Capital Boosts AngioDynamics Stake

Divisadero Street Capital Management and affiliates report an 8.4% beneficial ownership stake in AngioDynamics, Inc. common stock.

Summary

• Divisadero Street Capital Management, LP, William Zolezzi, and Divisadero Street Capital, LLC collectively report beneficial ownership of 3,395,430 shares of AngioDynamics, Inc. common stock.
• This ownership represents 8.4% of the outstanding common stock of AngioDynamics, Inc.
• Divisadero Street Partners, L.P. and Divisadero Street Partners GP, LLC report beneficial ownership of 3,054,469 shares, representing 7.5% of the class.
• All reported shares are held with shared voting and shared dispositive power among the respective reporting entities.
• The securities were not acquired for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.

Sentiment

Score: 6

Explanation: The filing is a factual disclosure of beneficial ownership. While not directly positive or negative about the company's performance, a significant stake by an investment firm can be perceived as a positive signal of investor confidence, hence a slightly positive score.

Positives

• Increased institutional ownership by an investment firm may signal confidence in AngioDynamics, Inc.'s long-term prospects.

Future Outlook

NA

Industry Context

This filing indicates a significant passive investment by Divisadero Street Capital Management and its affiliates in AngioDynamics, Inc., a company operating in the medical device sector. Such disclosures are common for investment firms accumulating stakes in publicly traded companies, reflecting their investment strategies rather than direct operational insights into the issuer's industry trends.

Related Party Transactions

• All securities reported are directly owned by advisory clients of Divisadero Street Capital Management, LP. Divisadero Street Partners, L.P. is identified as an advisory client that may beneficially own more than 5% of the common stock.

Stakeholder Impact

• Shareholders may view the increased institutional ownership as a positive indicator of investor interest and potential long-term value.

Key Dates

Keywords

AngioDynamics, Divisadero Street Capital, Institutional Ownership, SEC Filing, Schedule 13G, Common Stock, Investment Management, Medical Devices